Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk (TIERRA)

Viatris

Status: Completed

Conditions: Erectile Dysfunction

Study type: Observational

Funder types: Industry

Identifiers

NCT00874185

A1481256

Details and patient eligibility

About

Evaluate satisfaction in people treated with IPDE5 inhibitors over time

Full description

12 first patients that are eligible

Enrollment: 720 patients

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• CV risk factors
• Male above 18

Exclusion criteria

• Non-informed consent

Trial design

720 participants in 1 patient group

Questionnaire

Description:

filling in questionnaires